또한 MTX 치료에도 불구하고 활성 상태를 유지했던 RA 환자의 경우 bDMARD를 투여받으면서 12개월 동안의 방사선 진행이중단되었다.
In addition, radiographic progression at 12 months in patients with RA who remained active despite of MTX treatment was halted when they received bDMARDs.